BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31073532)

  • 1. Aspirin Exposure and Mortality Risk among Prostate Cancer Patients: A Systematic Review and Meta-Analysis.
    Fan LL; Xie CP; Wu YM; Gu XJ; Chen YH; Wang YJ
    Biomed Res Int; 2019; 2019():9379602. PubMed ID: 31073532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis.
    Zhou J; Xia S; Li T; Liu R
    BMC Cancer; 2019 Dec; 19(1):1186. PubMed ID: 31805980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and mortality of patients with prostate cancer: a meta-analysis.
    Meng Y; Liao YB; Xu P; Wei WR; Wang J
    Onco Targets Ther; 2016; 9():1689-96. PubMed ID: 27051303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.
    Liu Y; Chen JQ; Xie L; Wang J; Li T; He Y; Gao Y; Qin X; Li S
    BMC Med; 2014 Mar; 12():55. PubMed ID: 24678716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
    Wedde TB; Småstuen MC; Brabrand S; Fosså SD; Kaasa S; Tafjord G; Russnes KM; Hellebust TP; Lilleby W
    Radiother Oncol; 2019 Mar; 132():211-217. PubMed ID: 30389241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
    Zhou CK; Daugherty SE; Liao LM; Freedman ND; Abnet CC; Pfeiffer R; Cook MB
    Cancer Prev Res (Phila); 2017 Jul; 10(7):410-420. PubMed ID: 28507039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer.
    Jacobs EJ; Newton CC; Stevens VL; Campbell PT; Freedland SJ; Gapstur SM
    J Clin Oncol; 2014 Nov; 32(33):3716-22. PubMed ID: 25332245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate intake and the risk of prostate cancer.
    Fan LL; Su HX; Gu XJ; Chen YH; Nan CJ
    Clin Chim Acta; 2018 Sep; 484():60-71. PubMed ID: 29778541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.
    Choe KS; Cowan JE; Chan JM; Carroll PR; D'Amico AV; Liauw SL
    J Clin Oncol; 2012 Oct; 30(28):3540-4. PubMed ID: 22927523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of prostate cancer mortality and cardiovascular mortality of nonmetastatic prostate cancer patients: A population-based retrospective cohort study.
    Matthes KL; Pestoni G; Korol D; Van Hemelrijck M; Rohrmann S
    Urol Oncol; 2018 Jun; 36(6):309.e15-309.e23. PubMed ID: 29576269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
    Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
    Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How socioeconomic and clinical factors impact prostate-cancer-specific and other-cause mortality in prostate cancer stratified by clinical stage: Competing-risk analysis.
    He H; Han D; Xu F; Lyu J
    Prostate; 2022 Mar; 82(4):415-424. PubMed ID: 34927741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aspirin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from randomized controlled trials and real-world studies.
    Ma S; Xia W; Wu B; Sun C; Jiang Y; Liu H; Lowe S; Zhou Z; Xie P; Gao J; Feng L; Guo X; Qu G; Sun Y
    Eur J Clin Pharmacol; 2023 Nov; 79(11):1475-1503. PubMed ID: 37648741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
    Grytli HH; Fagerland MW; Fosså SD; Taskén KA
    Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.
    FitzGerald LM; Zhao S; Leonardson A; Geybels MS; Kolb S; Lin DW; Wright JL; Eeles R; Kote-Jarai Z; Govindasami K; Giles GG; Southey MC; Schleutker J; Tammela TL; Sipeky C; Penney KL; Stampfer MJ; Gronberg H; Wiklund F; Stattin P; Hugosson J; Karyadi DM; Ostrander EA; Feng Z; Stanford JL
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):228-237. PubMed ID: 29298992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer.
    Raldow AC; Zhang D; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
    JAMA Oncol; 2015 Jun; 1(3):334-40. PubMed ID: 26181182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy.
    Raldow AC; Zhang D; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
    Brachytherapy; 2015; 14(6):781-7. PubMed ID: 26361718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical prostatectomy in Denmark: Survival analysis and temporal trends in clinicopathological parameters with up to 20 years of follow-up.
    Heering M; Berg KD; Brasso K; Iversen P; Røder MA
    Surg Oncol; 2017 Mar; 26(1):21-27. PubMed ID: 28317581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin Use Is Associated with Better Prognosis of Patients with Prostate Cancer after Definite Therapies: A Systematic Review and Meta-Analysis of Cohort Studies.
    An Y; Sun JX; Xu MY; Liu CQ; Xu JZ; Zhong XY; Hu J; Xia QD; Hu HL; Wang SG
    J Oncol; 2022; 2022():9275466. PubMed ID: 36425939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.
    Downer MK; Allard CB; Preston MA; Gaziano JM; Stampfer MJ; Mucci LA; Batista JL
    Eur Urol; 2017 Nov; 72(5):821-827. PubMed ID: 28189429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.